Literature DB >> 29499131

Dynamic Regulation of Long-Chain Fatty Acid Oxidation by a Noncanonical Interaction between the MCL-1 BH3 Helix and VLCAD.

Silvia Escudero1, Elma Zaganjor2, Susan Lee1, Christopher P Mill3, Ann M Morgan1, Emily B Crawford1, Jiahao Chen4, Thomas E Wales5, Rida Mourtada1, James Luccarelli1, Gregory H Bird1, Ulrich Steidl4, John R Engen5, Marcia C Haigis2, Joseph T Opferman6, Loren D Walensky7.   

Abstract

MCL-1 is a BCL-2 family protein implicated in the development and chemoresistance of human cancer. Unlike its anti-apoptotic homologs, Mcl-1 deletion has profound physiologic consequences, indicative of a broader role in homeostasis. We report that the BCL-2 homology 3 (BH3) α helix of MCL-1 can directly engage very long-chain acyl-CoA dehydrogenase (VLCAD), a key enzyme of the mitochondrial fatty acid β-oxidation (FAO) pathway. Proteomic analysis confirmed that the mitochondrial matrix isoform of MCL-1 (MCL-1Matrix) interacts with VLCAD. Mcl-1 deletion, or eliminating MCL-1Matrix alone, selectively deregulated long-chain FAO, causing increased flux through the pathway in response to nutrient deprivation. Transient elevation in MCL-1 upon serum withdrawal, a striking increase in MCL-1 BH3/VLCAD interaction upon palmitic acid titration, and direct modulation of enzymatic activity by the MCL-1 BH3 α helix are consistent with dynamic regulation. Thus, the MCL-1 BH3 interaction with VLCAD revealed a separable, gain-of-function role for MCL-1 in the regulation of lipid metabolism.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BCL-2 family; MCL-1; VLCAD; apoptosis; fatty acid metabolism; mitochondria; mitochondrial matrix; stapled peptide; α helix; β-oxidation

Mesh:

Substances:

Year:  2018        PMID: 29499131      PMCID: PMC5916823          DOI: 10.1016/j.molcel.2018.02.005

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  59 in total

1.  PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2.

Authors:  Natalie J German; Haejin Yoon; Rushdia Z Yusuf; J Patrick Murphy; Lydia W S Finley; Gaëlle Laurent; Wilhelm Haas; F Kyle Satterstrom; Jlenia Guarnerio; Elma Zaganjor; Daniel Santos; Pier Paolo Pandolfi; Andrew H Beck; Steven P Gygi; David T Scadden; William G Kaelin; Marcia C Haigis
Journal:  Mol Cell       Date:  2016-09-15       Impact factor: 17.970

2.  Expression and characterization of mutations in human very long-chain acyl-CoA dehydrogenase using a prokaryotic system.

Authors:  Eric S Goetzman; Yudong Wang; Miao He; Al-Walid Mohsen; Brittani K Ninness; Jerry Vockley
Journal:  Mol Genet Metab       Date:  2007-03-19       Impact factor: 4.797

3.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

6.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

7.  Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1.

Authors:  Joseph T Opferman; Anthony Letai; Caroline Beard; Mia D Sorcinelli; Christy C Ong; Stanley J Korsmeyer
Journal:  Nature       Date:  2003-12-11       Impact factor: 49.962

8.  Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.

Authors:  Pilar Caro; Amar U Kishan; Erik Norberg; Illana A Stanley; Bjoern Chapuy; Scott B Ficarro; Klaudia Polak; Daniel Tondera; John Gounarides; Hong Yin; Feng Zhou; Michael R Green; Linfeng Chen; Stefano Monti; Jarrod A Marto; Margaret A Shipp; Nika N Danial
Journal:  Cancer Cell       Date:  2012-10-16       Impact factor: 31.743

9.  MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation.

Authors:  Kyung-Min Lee; Jennifer M Giltnane; Justin M Balko; Luis J Schwarz; Angel L Guerrero-Zotano; Katherine E Hutchinson; Mellissa J Nixon; Mónica V Estrada; Violeta Sánchez; Melinda E Sanders; Taekyu Lee; Henry Gómez; Ana Lluch; J Alejandro Pérez-Fidalgo; Melissa Magdalene Wolf; Gabriela Andrejeva; Jeffrey C Rathmell; Stephen W Fesik; Carlos L Arteaga
Journal:  Cell Metab       Date:  2017-10-03       Impact factor: 27.287

10.  Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction.

Authors:  Xi Wang; Madhavi Bathina; John Lynch; Brian Koss; Christopher Calabrese; Sharon Frase; John D Schuetz; Jerold E Rehg; Joseph T Opferman
Journal:  Genes Dev       Date:  2013-06-15       Impact factor: 11.361

View more
  18 in total

1.  Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor.

Authors:  Gregory H Bird; Accalia Fu; Silvia Escudero; Marina Godes; Kwadwo Opoku-Nsiah; Thomas E Wales; Michael D Cameron; John R Engen; Nika N Danial; Loren D Walensky
Journal:  ACS Chem Biol       Date:  2020-05-27       Impact factor: 5.100

Review 2.  Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins.

Authors:  Rumani Singh; Anthony Letai; Kristopher Sarosiek
Journal:  Nat Rev Mol Cell Biol       Date:  2019-03       Impact factor: 94.444

Review 3.  A "Weird" Mitochondrial Fatty Acid Oxidation as a Metabolic "Secret" of Cancer.

Authors:  Zhivko Zhelev; Ichio Aoki; Dessislava Lazarova; Tatyana Vlaykova; Tatsuya Higashi; Rumiana Bakalova
Journal:  Oxid Med Cell Longev       Date:  2022-02-08       Impact factor: 6.543

4.  The regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer's disease.

Authors:  Abdol-Hossein Rezaeian; Wenyi Wei; Hiroyuki Inuzuka
Journal:  Acta Mater Med       Date:  2022-01-28

5.  Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.

Authors:  Christi T Salisbury-Ruf; Clinton C Bertram; Aurelia Vergeade; Daniel S Lark; Qiong Shi; Marlene L Heberling; Niki L Fortune; G Donald Okoye; W Gray Jerome; Quinn S Wells; Josh Fessel; Javid Moslehi; Heidi Chen; L Jackson Roberts; Olivier Boutaud; Eric R Gamazon; Sandra S Zinkel
Journal:  Elife       Date:  2018-10-03       Impact factor: 8.140

6.  OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation.

Authors:  Qingyu Luo; Xiaowei Wu; Pengfei Zhao; Yabing Nan; Wan Chang; Xiaolin Zhu; Dan Su; Zhihua Liu
Journal:  Adv Sci (Weinh)       Date:  2021-02-08       Impact factor: 16.806

Review 7.  Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options.

Authors:  Xiaowei Wu; Qingyu Luo; Zhihua Liu
Journal:  Cell Death Dis       Date:  2020-07-22       Impact factor: 8.469

8.  MCL-1 Inhibition by Selective BH3 Mimetics Disrupts Mitochondrial Dynamics Causing Loss of Viability and Functionality of Human Cardiomyocytes.

Authors:  Megan L Rasmussen; Nilay Taneja; Abigail C Neininger; Lili Wang; Gabriella L Robertson; Stellan N Riffle; Linzheng Shi; Bjorn C Knollmann; Dylan T Burnette; Vivian Gama
Journal:  iScience       Date:  2020-03-30

9.  Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients.

Authors:  Qiong Gao; Elena López-Knowles; Maggie Chon U Cheang; James Morden; Ricardo Ribas; Kally Sidhu; David Evans; Vera Martins; Andrew Dodson; Anthony Skene; Chris Holcombe; Elizabeth Mallon; Abigail Evans; Judith M Bliss; John Robertson; Ian Smith; Lesley-Ann Martin; Mitch Dowsett
Journal:  Breast Cancer Res       Date:  2019-12-31       Impact factor: 6.466

10.  Glucose-dependent partitioning of arginine to the urea cycle protects β-cells from inflammation.

Authors:  Accalia Fu; Juan Carlos Alvarez-Perez; Daina Avizonis; Tatsuya Kin; Scott B Ficarro; Dong Wook Choi; Esra Karakose; Mehmet G Badur; Lindsay Evans; Carolina Rosselot; Gaelle Bridon; Gregory H Bird; Hyuk-Soo Seo; Sirano Dhe-Paganon; Jurre J Kamphorst; Andrew F Stewart; A M James Shapiro; Jarrod A Marto; Loren D Walensky; Russell G Jones; Adolfo Garcia-Ocana; Nika N Danial
Journal:  Nat Metab       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.